The high expression profile of PSMA and its localization in the PCa cell membrane have paved the way for its widespread theranostic applications, where the same molecular target is used for both diagnostic imaging and therapeutic intervention [18,28]. This evidence concerns the gene FOLH1 and posterior cortical atrophy.